Advances in systemic therapy for advanced pancreatobiliary malignancies

Thorvardur R Halfdanarson1, Sigurdis Haraldsdottir, Mitesh J Borad

  • 1Division of Hematology and Medical Oncology, Mayo Clinic Arizona, Scottsdale, AZ, USA.

F1000Research
|December 12, 2013
PubMed
Summary

Pancreatobiliary cancers have a poor prognosis despite recent treatment advances. This review covers current options for advanced disease and highlights novel targeted therapies for improved patient outcomes.